Antinociception and anti-inflammation induced by simvastatin in algesiometric assays in mice

Basic and Clinical Pharmacology and Toxicology

Volumn 109, Issue 6, 2011, Pages 438-442

  Miranda, Hugo F ^a   Noriega, Viviana ^a   Olavarria, Loreto ^a   Zepeda, Ramiro J ^a   Sierralta, Fernando ^a   Prieto, Juan C ^a,b  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; CYTOKINE; FORMALDEHYDE; NITRIC OXIDE; PROSTANOID; SIMVASTATIN;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; HINDLIMB; HOT PLATE TEST; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; TAIL FLICK TEST; WRITHING TEST;

ANALGESICS, NON-NARCOTIC; ANIMALS; ANTI-INFLAMMATORY AGENTS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; HOT TEMPERATURE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MICE; MICE, INBRED STRAINS; PAIN; PAIN MEASUREMENT;

MUS;

EID: 81255160924     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2011.00746.x     Document Type: Article

References (26)

1. Dinarello CA. Anti-inflammatory agents: present and future. Cell 2010;140:935-50.
2. Leung BP, Sattar N, Crilly A, Prach M, McCarey DW, Payne H et al. A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol 2003;170:1524-30.
3. Barsante MM, Roffe E, Yokoro CM, Tafuri WL, Souza DG, Pinho V et al. Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis. Eur J Pharmacol 2005;516:282-9.
4. Santodomingo-Garzon T, Cunha TM, Verri WA Jr, Valerio DA, Parada CA, Poole S et al. Atorvastatin inhibits inflammatory hypernociception. Br J Pharmacol 2006;149:14-22.
5. Hernandez-Romero MC, Arguelles S, Villaran RF, de Pablos RM, Delgado-Cortes MJ, Santiago M et al. Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide. J Neurochem 2008;105:445-59.
6. Ghaisas MM, Dandawate PR, Zawar SA, Ahire YS, Gandhi SP. Antioxidant, antinociceptive and anti-inflammatory activities of atrovastatin and rosuvastatin in various experimental models. Inflammopharmacol 2010;18:169-77.
7. Endo A, Tsujita Y, Kuroda M, Tanzawa K. Effects of ML-236 B on cholesterol metabolism in mice and rats: lack of hypocholesterolemic activity in normal animals. Biochim Biophys Acta 1979;575:266-76.
8. Rashid S, Curtis DE, Garuti R, Anderson NN, Bashmakov Y, Ho YK et al. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. Proc Natl Acad Sci U S A 2005;102:5374-9.
9. Liao JK, Laufs U. Pleiotropics effects of statins. Annu Rev Pharmacol Toxicol 2005;45:89-118.
10. Shi XQ, Lim TKY, Lee S, Zhao YQ, Zhang J. Statins alleviate experimental nerve injury-induced neuropathic pain. Pain 2011;152:1033-43.
11. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16:109-10.
12. Miranda HF, Puig MM, Romero MA, Prieto JC. Effects of tramadol and dexketoprofen on analgesia and gastrointestinal transit in mice. Fundam Clin Pharmacol 2009;23:81-8.
13. Miranda HF, Sierralta F, Prieto JC. Synergism between NSAIDs in the orofacial formalin test in mice. Pharmacol Biochem Behav 2009;92:314-8.
14. Raboisson P, Dallel R. The orofacial formalin test. Neurosci Biobehav Rev 2004;28:219-26.
15. Luccarini P, Childeric A, Gayder AM, Voisin D, Dallel R. The orofacial formalin test in the mouse, a behavioral model for studying physiology and modulation of trigeminal nociception. J Pain 2006;7:908-14.
16. Melendez L, Lastra A, Hidalgo A, Baamonde A. Unilateral hot plate: a simple and sensitive method for detecting central and peripheral hyperalgesia in mice. J Neurosci Methods 2002;113:91-7.
17. Tallarida RJ. Drug Synergism and Dose-Effect Data Analysis. Chapman & Hall CRC, Boca Raton, FL, 2000;1-69.
18. Goldstein A, Aronov L, Kalman SM. The Basis of Pharmacology, 2nd edn. John Wiley & Sons, New York, 1974.
19. Steffens S, Mach F. Anti-inflammatory properties of statins. Semin Vasc Med 2004;4:417-22.
20. Pahan K, Sheikh FG, Namboodiri AM, Singh I. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest 1997;100:2671-9.
21. Ferro D, Parrotto S, Basili S, Alessandri C, Violi F. Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia. J Am Coll Cardiol 2000;36:427-31.
22. + channel pathway. Proc Natl Acad Sci USA 2004;101:3680-5.
23. Kumar VL, Guruprasad B, Wahane VD. Atorvastatin exhibits anti-inflammatory and anti-oxidant properties in adjuvant-induced monoarthitis. Inflammopharmacol 2010;18:303-8.
24. Wahane VD, Kumar VL. Atorvastatin ameliorates inflammatory hyperalgesia in rat model of monoarticular arthritis. Pharmacol Res 2010;61:329-33.
25. Chen H, Ikeda U, Shimpo M, Ikeda M, Minota S, Shimada K. Fluvastatin upregulates inducible nitric oxyde synthase expression in cytokine-stimulated vascular smooth muscle cells. Hypertension 2000;36:923-8.
26. Anaboldi L, Corsini A. Do structural differences in statins correlate with clinical efficacy? Curr Opin Lipidol 2010;21:298-304.